Solstice Advanced Materials Inc. Common Stock SOLS

$62.65 +0.13% at last close

Analyst Consensus

Consensus Rating
Buy (4 Buy · 1 Hold · 0 Sell)
Average Price Target
$79.40
Implied Upside
+26.7%
Price Target Range
$70.00 – $90.00
Analysts (12 mo)
5

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-07-31
UBSJoshua Spector
Maintains Buy $78 → $80
2026-07-31
RBC CapitalArun Viswanathan
Maintains Outperform $102 → $82
2026-07-16
BMO CapitalJohn McNulty
Maintains Outperform $101 → $90
2026-07-15
MizuhoJohn Roberts
Maintains Neutral $95 → $70
2026-07-13
UBSJoshua Spector
Upgrades Neutral → Buy $88 → $78
2026-07-09
Truist SecuritiesPeter Osterland
Upgrades Hold → Buy $90 → $75
2026-07-01
MizuhoJohn Roberts
Maintains Neutral $85 → $95
2026-06-30
RBC CapitalArun Viswanathan
Maintains Outperform $100 → $102
2026-06-08
Truist SecuritiesPeter Osterland
Initiates coverage on Hold $90
2026-06-05
RBC CapitalArun Viswanathan
Maintains Outperform $94 → $100
2026-06-05
BMO CapitalJohn McNulty
Maintains Outperform $92 → $101
2026-05-08
UBSJoshua Spector
Maintains Neutral $87 → $88
2026-04-14
UBSJoshua Spector
Downgrades Buy → Neutral $87
2026-02-12
BMO CapitalJohn McNulty
Maintains Outperform $72 → $90
2026-02-12
MizuhoJohn Roberts
Maintains Neutral $54 → $65
2026-01-20
RBC CapitalArun Viswanathan
Upgrades Sector perform → Outperform $50 → $75
2026-01-12
UBSJoshua Spector
Maintains Buy $58 → $61
2025-11-25
UBSJoshua Spector
Maintains Buy $62 → $58
2025-11-10
RBC CapitalArun Viswanathan
Initiates coverage on Sector perform $50
2025-11-03
UBSJoshua Spector
Initiates coverage on Buy $62
2025-10-31
MizuhoJohn Roberts
Initiates coverage on Neutral $54

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$62.65
Market Cap
$9.95 billion
52-Week Range
$40.43 $90.80
Average Volume
4.12 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.